[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001205:Ascorbic Acid / Q000627:therapeutic use*; D003676:Deferoxamine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006432:Hemochromatosis / Q000188:drug therapy*; D006486:Hemosiderosis / Q000188:drug therapy*; D006801:Humans; D007501:Iron / Q000652:urine; D008297:Male; D008875:Middle Aged; D013789:Thalassemia / Q000188:drug therapy*
D007501:Iron; D003676:Deferoxamine; D001205:Ascorbic Acid
Nuove esperienze nella terapia ferrochelante (desferrioxamina e acido ascorbico) delle siderocromatosi e del morbo di Cooley.